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General Information 
All metathesis reactions were setup in a Vacuum Atmospheres glovebox 
under a nitrogen atmosphere. Solvents were purified by passage through solvent 
purification columns and further degassed with Argon.1 Commercially available 
liquid reagents were degassed by three freeze pump thaw cycles (for volatile 
substrates) or under vacuum (for nonvolatile substrates) prior to entering the 
glove box. Stock solutions of the cyclometalated ruthenium catalysts were 
prepared in the glovebox, stored at -35 °C in the glovebox freezer, and used 
within four weeks. Sodium periodate and CeCl3 heptahydrate were purchased 
from Aldrich and used as is. 
 Standard NMR spectroscopy experiments were conducted on a Varian 
INOVA 500 (1H: 500 MHz, 13C: 126 MHz) or a Bruker Avance HD 400 (1H: 400 
MHz, 13C: 101 MHz, equipped with a cryoprobe) spectrometer. Chemical shifts 
are referenced to the residual solvent peak (CDCl3, C6D6 or DMSO-d6). 
Multiplicity is reported as follows: (s: singlet, d: doublet, t: triplet: q: quartet, br: 
broad, m: multiplet). Spectra were analyzed and processed using MestReNova. 
High-resolution mass spectra were provided by the California Institute of 
Technology Mass Spectrometry Facility using JEOL JMS-600H High Resolution 
Mass Spectrometer. 
  
                                                        
1 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J., 
Organometallics 1996, 15, 1518-1520. 
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Synthesis of substrates 
 
 
Allyl (4-methoxyphenyl)carbamate (5e): To a flame dried round bottom flask 
under argon was added p-anisidine (1.85 g, 15 mmol, 1 equiv), CH2Cl2 (45 mL) 
and diisopropylethylamine (2.79 mL, 16 mmol, 1.07 equiv), and the flask was 
cooled to 0 °C and stirred. Allyl chloroformate (1.70 mL, 16 mmol, 1.07 equiv) 
was then added dropwise. After 30 min, the flask was allowed to warm to 
ambient temperature and stirred for an additional 30 min. The reaction mixture 
was quenched with 20 mL HCl (1M) and extracted with 150 mL EtOAc. The 
organic extract was then washed with saturated NaHCO3 (20 mL), brine (20 mL), 
and then dried with Na2SO4 and concentrated in vacuo. The title compound was 
isolated by column chromatography (15 – 30% EtOAc in Hexanes) to give a 
white solid (2.853 g, 92%). 1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 8.2 Hz, 2H), 
6.85 (d, J = 9.1 Hz, 2H), 6.52 (br s, 1H), 5.97 (ddt, J = 16.9, 10.4, 5.7 Hz, 2H), 
5.35 (dd, J = 17.2, 1.6 Hz, 2H), 5.25 (dd, J = 10.5, 1.3 Hz, 1H), 4.66 (dt, J = 5.7, 
1.4 Hz, 4H), 3.78 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 156.2, 153.7, 132.7, 
131.0, 120.8, 118.3, 114.4, 65.9, 55.7. HRMS (FAB+): m/z calculated for 
[C11H13O3N]+: 207.0895; found: 207.0895.  
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Allyl (4-methylbenzyl)carbamate (5f): To a flame dried round bottom flask 
under argon was added 4-methylbenzylamine (1.91 mL, 15 mmol, 1 equiv), 
CH2Cl2 (45 mL) and diisopropylethylamine (2.79 mL, 16 mmol, 1.07 equiv), and 
the flask was cooled to 0 °C and stirred. Allyl chloroformate (1.70 mL, 16 mmol, 
1.07 equiv) was then added dropwise. After 30 min, the flask was allowed to 
warm to ambient temperature and stirred for an additional 30 min. The reaction 
mixture was quenched with 20 mL HCl (1M) and extracted with 150 mL EtOAc. 
The organic extract was then washed with saturated NaHCO3 (20 mL), brine (20 
mL), and then dried with Na2SO4 and concentrated in vacuo. The title compound 
was isolated by column chromatography (15 – 30% EtOAc in Hexanes) to give a 
white solid (2.655 g, 86%). 1H NMR (400 MHz, CDCl3) δ 7.18 (d, J = 8.1 Hz, 2H), 
7.14 (d, J = 8.3 Hz, 2H), 5.93 (ddt, J = 17.2, 10.4, 5.6 Hz, 1H), 5.31 (dd, J = 17.1, 
1.6 Hz, 1H), 5.21 (dq, J = 10.5, 1.4 Hz, 1H), 4.99 (br s, 1H), 4.60 (d, J = 6.0 Hz, 
2H), 4.34 (d, J = 5.9 Hz, 2H), 2.34 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 156.4, 
137.3, 135.5, 133.0, 129.5, 127.7, 117.8, 65.8, 45.0, 21.2. HRMS (FAB+): m/z 
calculated for [C12H15O2N+H]+: 206.1181; found: 206.1183. 
 
 
Benzyl allylcarbamate (5h): Prepared according to a literature procedure, and 
the spectroscopic data matched the literature data.2 
 
  
                                                        
2 H. Teller, M. Corbet, L. Mantilli, G. Gopakumar, R. Goddard, W. Thiel, A. 
Fürstner, J. Am. Chem. Soc. 2012, 134, 15331–15342. 
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General procedures and product characterization  
 
General procedure A: Optimization for tandem Z-selective 
homodimerization – dihydroxylation: In a nitrogen filled glove box, allyl 
butyrate (25.6 mg, 0.2 mmol, 1 eq) was transferred to a 25 mL Schlenk tube 
using three 50 µL portions of a solution of the appropriate metathesis catalyst 
(0.003 mmol, 1.5 mol%, 150 µL, 0.02M in THF) to ensure quantitative transfer. 
The tube was capped, and then brought to a Schlenk line where it was 
evacuated using one freeze-pump-thaw cycle, capping the flask under static 
vacuum. The solution was then heated in an oil bath with stirring at 40 °C for 4 hr. 
A solution of the appropriate Lewis acid (10 mol %) in distilled H2O (170 µL) was 
added to NaIO4 (42.8 mg, 0.2 mmol, 2 eq relative to the homodimerization 
metathesis product at full conversion). MeCN (500 µL) was then added, and the 
mixture was cooled to 0 °C in an ice bath. The crude metathesis mixture was 
then added, using ethyl acetate (3 x 167 µL) to rinse the flask and ensure 
complete transfer. The mixture was vigorously stirred at 0 °C for 20 min and then 
quenched with 2 mL of a saturated Na2S2O3 aqueous solution. The mixture was 
extracted with ethyl acetate (4 x 2.5 mL), and then concentrated under reduced 
pressure. Mesitylene (27.8 µL, 0.2 mmol) was added as an internal standard, and 
the mixture was dissolved in CDCl3 for NMR studies (1H NMR, 8 scans, 25 s 
relaxation delay). 
Note: For Table 1, entry 6, ethyl vinyl ether (0.2 mmol, 18.6 µL) was added after 
the metathesis step, and the mixture was stirred for 20 minutes at ambient 
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temperature. Subsequently, the volatiles were removed and the mixture was 
dissolved in ethyl acetate to add to the oxidation mixture.  
 
General procedure B: Z-selective homodimerization under static vacuum. In 
a nitrogen filled glove box, the terminal olefin was transferred to a 25 mL Schlenk 
tube using three 50 µL portions of a solution of Ad-DIPP-NO3 4 (0.003 mmol, 1.5 
mol%, 150 µL, 0.02M in THF) to ensure quantitative transfer. The tube was 
capped, and then brought to a Schlenk line where it was evacuated using one 
freeze-pump-thaw cycle, capping the flask under static vacuum. The solution was 
then heated in an oil bath with stirring at 40 °C for 4 hr. 
 
General procedure C: Z-selective homodimerization in an open vial. In a 
nitrogen filled glove box, a solution of Ad-DIPP-NO3 4 (0.001 mmol, 0.5 mol%, 
200 µL, 0.005M in THF) was added to the terminal olefin (0.2 mmol, 1 eq) in a 2 
dram vial. The mixture was stirred in an open vial in the glove box at 40 °C for 3 
hr. 
 
General procedure D: Dihydroxylation for 0.2 mmol scale 
homodimerizations. A solution of CeCl3 heptahydrate (3.7 mg, 0.01 mmol, 10 
mol%) in distilled H2O (170 µL) was added to NaIO4 (42.8 mg, 0.2 mmol, 2 eq 
relative to the homodimerization metathesis product at full conversion). MeCN 
(500 µL) was then added, and the mixture was cooled to 0 °C in an ice bath. The 
crude metathesis mixture was then added, using ethyl acetate (3 x 167 µL) to 
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rinse the flask and ensure complete transfer. The mixture was vigorously stirred 
at 0 °C for 20 min and then quenched with 2 mL of a saturated Na2S2O3 aqueous 
solution. The mixture was extracted with ethyl acetate (4 x 2.5 mL), and then 
concentrated under reduced pressure. The anti-diol product was purified by 
column chromatography. 
 
General procedure E: Z-selective cross metathesis in an open vial followed 
by dihydroxylation. In a nitrogen filled glove box, a solution the excess olefin 
reagent (0.5 mmol, 5 eq) in THF (150 µL) was added to the limiting olefin reagent 
(0.1 mmol, 1 eq) in a 2 dram vial. A solution of Ad-DIPP-NO3 4 (0.003 mmol, 3 
mol%, 150 µL, 0.02 M in THF) was added. The mixture was stirred in the open 
vial in the glove box at 40 °C for 4 hr. A solution of CeCl3 heptahydrate (11.2 mg, 
0.03 mmol) in distilled H2O (0.5 mL) was added to NaIO4 (128.3 mg, 0.6 mmol). 
MeCN (1.5 mL) was then added, and the mixture was cooled to 0 °C in an ice 
bath. The crude metathesis mixture was then added, using ethyl acetate (3 x 0.5 
mL) to rinse the flask and ensure complete transfer. The mixture was vigorously 
stirred at 0 °C for 20 min and then quenched with 6 mL of a saturated Na2S2O3 
aqueous solution. The mixture was extracted with ethyl acetate (4 x 4 mL), and 
then concentrated under reduced pressure. The anti-diol product was purified by 
column chromatography. 
 
Note: For all substrates, an independent metathesis reaction under identical 
conditions as the tandem process was performed and the Z-selectivity assessed 
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by 1H NMR, to ensure that isomerization did not occur in the time scale of the 
metathesis. Z-selectivity was >90% in all cases. The 1H NMR signals were 
compared to those observed in an early conversion (30 minute) metathesis 
reaction, (1 mol% 4, reaction in an open vial), to aid in peak assignment. In 
general, static vacuum conditions for the metathesis step were successful in 
minimizing Z to E isomerization (due to removal of ethylene from solution). An 
alternative strategy to remove ethylene from the reaction is to perform the 
metathesis step in an open vial inside an inert atmosphere glove box. This was 
an effective strategy for substrates which are not volatile and do not become 
highly viscous or solid upon loss of solvent during cross metathesis. This open 
vial procedure was used for allyl phenyl carbonate and the hetero cross 
metathesis / dihydroxylation reactions.  
 
 
Anti-2,3-dihydroxybutane-1,4-diyl dibutyrate (6a): Synthesized according to 
the general procedure B for homodimerization under static vacuum followed by 
the general procedure D for dihydroxylation. The title compound was purified by 
column chromatography (50-75% ethyl acetate in hexanes). This material was 
then triturated with ether to afford a white solid (18.8 mg, 72%). 1H NMR (500 
MHz, DMSO-d6) δ 4.34-4.31 (m, 4H), 3.80-3.75 (m, 2H), 2.90-2.70 (br s, 2H), 
2.35 (t, J = 7.4 Hz, 4H), 1.67 (hex, J = 7.4 Hz, 4H), 0.95 (t, J = 7.4 Hz, 6H); 13C 
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NMR (126 MHz, CDCl3) δ 174.7, 70.6, 65.6, 36.1, 18.5, 13.8. HRMS (FAB+): m/z 
calculated for [C12H22O6+H]+: 263.1495; found: 263.1490. 
 
 
Anti-2,3-dihydroxybutane-1,4-diyl diacetate (6b): Synthesized according to the 
general procedure B for homodimerization under static vacuum followed by the 
general procedure D for dihydroxylation. The title compound was isolated by 
column chromatography (60-80% ethyl acetate in hexanes) to give a clear oil 
(12.2 mg, 59%). Spectroscopic data matched literature data.3 1H NMR (400 MHz, 
DMSO-d6) δ 4.36-4.26 (m, 4H), 3.79 (s, 2H), 2.80 (br s), 2.12 (s, 6H); 13C NMR 
(101 MHz, CDCl3) δ 172.0, 70.5, 65.8, 21.0; HRMS (FAB+): m/z calculated for 
[C8H14O6+H]+: 207.0869; found: 207.0861. 
 
 
Anti-2,3-dihydroxybutane-1,4-diyl dibenzoate (6c): Synthesized according to 
the general procedure B for homodimerization under static vacuum followed by 
the general procedure D for dihydroxylation. The title compound was purified by 
column chromatography (60-80% ethyl acetate in hexanes). This material was 
then triturated with ether to afford a white solid (23.4 mg, 71%) which was 
sparingly soluble in CDCl3 but soluble in DMSO. 1H NMR (500 MHz, DMSO-d6) δ 
                                                        
3 T. K. M. Shing, E. K. W. Tam, V. W.-F. Tai, I. H. F. Chung, Q. Jiang, Chem. – Eur. J. 1996, 
2, 50–57. 
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8.03 (dd, J = 8.4, 1.3 Hz, 4H), 7.66 (tt, J = 7.5, 1.5 Hz, 2H), 7.53 (t, J = 7.5 Hz, 
4H), 5.36 (d, J = 5.9 Hz, 2H), 4.50 (dd, J = 11.3, 2.1 Hz, 2H), 4.31 (dd, J = 11.2, 
5.7 Hz, 2H), 3.87-3.83 (m, 2H); 13C NMR (126 MHz, DMSO-d6) δ 165.9, 133.3, 
130.0, 129.3, 128.7, 69.2, 66.7. HRMS (FAB+): m/z calculated for [C18H18O6+H]+: 
331.1182; found: 331.1182. 
Procedure for large scale synthesis: In a nitrogen filled glove box, a solution of 
Ad-DIPP-NO3 4 (20.8 mg, 0.0309 mmol, 0.5 mol%) in THF (2.17 mL) was added 
to allyl benzoate (1.0 g, 6.17 mmol) in a 10 dram vial. The mixture was stirred in 
an open vial in the glove box at 40 °C for 7.5 hr. A solution of CeCl3 heptahydrate 
(115 mg, 0.309 mmol) in distilled H2O (5.1 mL) was added to NaIO4 (1.32 g, 6.17 
mmol, 2 eq relative to the homodimerization metathesis product at full 
conversion) in a round bottom flask. MeCN (15.4 mL) was then added, and the 
mixture was cooled to 0 °C in an ice bath. The crude metathesis mixture was 
then added, using ethyl acetate (3 x 5.1 mL) to rinse the flask and ensure 
complete transfer. The mixture was vigorously stirred at 0 °C for 20 min and then 
quenched with 25 mL of a saturated Na2S2O3 aqueous solution. The mixture was 
extracted with ethyl acetate (3 x 60 mL), dried with Na2SO4 and then 
concentrated under reduced pressure. The resulting solid was then triterated with 
diethyl ether (5 x 5 mL) to give the title compound as a white solid (669 mg, 66%). 
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Anti-2,3-dihydroxybutane-1,4-diyl diphenyl bis(carbonate) (6d): Synthesized 
according to the general procedure C for homodimerization in an open vial 
followed by the general procedure D for dihydroxylation. The title compound was 
purified by column chromatography (60–75% ether in pentane) to give a white 
solid (22.1 mg, 61%). 1H NMR (400 MHz, CDCl3) δ 7.42 (dd, J = 8.6, 7.3 Hz, 4H), 
7.35 – 7.24 (m, 2H), 7.24 – 7.14 (m, 4H), 4.64 – 4.54 (m, 2H), 4.54 – 4.45 (m, 
2H), 4.08 – 3.97 (m, 2H), 2.67 (br s, 2H). 13C NMR (101 MHz, CDCl3) δ 154.1, 
151.0, 129.6, 126.3, 120.9, 70.0, 69.5. HRMS (FAB+): m/z calculated for 
[C18H18O8+H]+: 363.1080; found: 363.1081. 
 
 
Anti-2,3-dihydroxybutane-1,4-diyl bis((4-methoxyphenyl)carbamate) (6e): 
Synthesized according to the general procedure B for homodimerization under 
static vacuum followed by the general procedure D for dihydroxylation. The title 
compound was purified by column chromatography (80-100% ethyl acetate in 
hexanes) followed by trituration of the impure fractions with diethyl ether to afford 
a white solid (26.6 mg, 63%). 1H NMR (400 MHz, DMSO-d6) δ 9.45 (br s, 2H), 
7.37 (d, J = 8.6 Hz, 4H), 6.85 (d, J = 8.9 Hz, 4H), 5.07 (d, J = 4.8 Hz, 2H), 4.29 
(dd, J = 11.4, 2.3 Hz, 2H), 4.04 (dd, J = 11.1, 5.5 Hz, 2H), 3.70 (s, 6H), 3.7-3.65 
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(m, 2H); 13C NMR (101 MHz, CDCl3) δ 154.7, 153.9, 132.3, 119.7, 113.9, 69.7, 
66.1, 55.1; HRMS (FAB+): m/z calculated for [C20H24O8N2+H]+: 421.1611; found: 
421.1606. 
 
Anti-2,3-dihydroxybutane-1,4-diyl bis((4-methylbenzyl)carbamate) (6f): 
Synthesized according to the general procedure B for homodimerization under 
static vacuum followed by the general procedure D for dihydroxylation. The title 
compound was purified by column chromatography (80% ethyl acetate in 
hexanes to 10% MeOH in ethyl acetate) followed by trituration with diethyl ether 
to afford a pale yellow solid (16.4 mg, 39%). 1H NMR (400 MHz, DMSO-d6) δ 
7.61 (t, J = 6.2 Hz, 1H), 7.16-7.08 (m, 8H), 4.93 (d, J = 4.9 Hz, 2H), 4.20-4.10 (m, 
8H), 3.91 (dd, J = 11.4, 5.7 Hz, 2H), 3.57 – 3.51 (m, 2H), 2.27 (s, 6H); 13C NMR 
(101 MHz, DMSO) δ 156.7, 136.9, 135.7, 128.8, 127.0, 69.9, 66.0, 43.5, 20.7; 
HRMS (FAB+): m/z calculated for [C22H28O6N2+H]+: 417.2026; found: 417.2036. 
 
 
N,N'-((Anti)-2,3-dihydroxybutane-1,4-diyl)bis(4-methylbenzenesulfonamide) 
(6g): Synthesized according to the general procedure B for homodimerization 
under static vacuum followed by the general procedure D for dihydroxylation. The 
title compound was purified by column chromatography (80% ethyl acetate in 
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hexanes) to give a white solid (30.1 mg, 70%). 1H NMR (500 MHz, CDCl3) δ 7.66 
(d, J = 8.2 Hz, 4H), 7.38 (d, J = 8.1 Hz, 4H), 7.28 (dd, J = 6.8, 5.4 Hz, 2H), 4.88 
(br s, 2H), 3.23 (d, J = 7.0 Hz, 2H), 2.98 (ddd, J = 12.7, 6.9, 2.2 Hz, 2H), 2.56-
2.50 (m, 2H), 2.37 (s, 6H); 13C NMR (126 MHz, DMSO) δ 142.55, 137.52, 129.60, 
126.65, 71.26, 46.22, 21.01. HRMS (FAB+) m/z calculated for 
[C18H24O6S2N2+H]+: 429.1154; found: 429.1175. 
 
 
Dibenzyl ((Anti)-2,3-dihydroxybutane-1,4-diyl)dicarbamate (6h): Synthesized 
according to the general procedure B for homodimerization under static vacuum 
followed by the general procedure D for dihydroxylation. The title compound was 
purified by column chromatography (60–85% ethyl acetate in hexanes) to give a 
white solid (20.7 mg, 53%). 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.34 (m, 10H), 
5.25 (br s, 2H), 5.12 (s, 4H), 3.91 (br s, 2H), 3.66 (dd, J = 15.0, 7.8 Hz, 2H), 3.46 
(s, 2H), 3.30 (d, J = 14.8 Hz, 2H). 13C NMR (101 MHz, DMSO) δ 156.8, 137.7, 
128.8, 128.2, 128.2, 71.9, 65.7, 44.5. HRMS (FAB+) m/z calculated for 
[C20H24O6N2+H]+: 389.1713; found: 389.1721. 
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(Anti)-2,3-dihydroxy-4-((4-methylphenyl)sulfonamido)butyl butyrate (6i): 
Synthesized according to general procedure E for cross metathesis – 
dihydroxylation using allyl butyrate as the olefin in excess. The metathesis was 
performed at 35 °C using 1.5 mol% Ru (0.0015 mmol). The title compound was 
purified by column chromatography (50-70% ethyl acetate in hexanes) to give a 
white solid (21.8 mg, 63%). 1H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 8.3 Hz, 2H), 
7.30 (d, J = 7.9 Hz, 2H), 5.51 (t, J = 6.5 Hz, 1H), 4.33-4.22 (m, 2H), 3.82 (br s, 
1H), 3.62 (br s, 1H), 3.48 (d, J = 5.5 Hz, 1H), 3.22 – 3.07 (m, 3H), 2.42 (s, 3H), 
2.32 (t, J = 7.5 Hz, 2H), 1.63 (hex, J = 7.4 Hz, 2H), 0.93 (t, J = 7.4 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 175.0, 143.9, 136.5, 130.0, 127.2, 71.1, 70.3, 65.6, 
45.3, 36.1, 21.7, 18.5, 13.8. HRMS (FAB+) m/z calculated for [C15H23O6SN+H]+: 
346.1324; found: 346.1315. 
 
 
Anti-2,3-dihydroxy-4-((4-methylphenyl)sulfonamido)butyl benzoate (6j): 
Synthesized according to general procedure E for cross metathesis – 
dihydroxylation using allyl benzoate as the olefin in excess. The title compound 
was purified by column chromatography (50-60% ethyl acetate in hexanes) 
followed by preparatory thin layer chromatography (60% ethyl acetate in 
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hexanes) to give a white solid (14.6 mg, 39%). 1H NMR (400 MHz, DMSO-d6) δ 
7.99 (d, J = 8.5 Hz, 2H), 7.70 (d, J = 8.3 Hz, 2H), 7.66 (tt, J = 7.6, 1.6 Hz, 1H), 
7.53 (t, J = 7.6 Hz, 2H), 7.42-7.36 (m, 1H), 7.38 (d, J = 7.7 Hz, 2H), 5.16 (d, J = 
5.7 Hz, 1H), 5.06 (d, J = 5.7 Hz, 1H), 4.37 (dd, J = 11.3, 2.8 Hz, 1H), 4.18 (dd, J 
= 11.3, 5.8 Hz, 1H), 3.63 – 3.47 (m, 2H), 3.11 (ddd, J = 12.7, 6.8, 3.1 Hz, 1H), 
2.67 (ddd, J = 12.8, 7.7, 5.4 Hz, 1H), 2.37 (s, 3H); 13C NMR (101 MHz, DMSO-
d6) δ 165.8, 142.5, 137.6, 133.2, 129.9, 129.5, 129.3, 128.6, 126.6, 70.3, 70.1, 
66.5, 46.4, 21.0. HRMS (FAB+): m/z calculated for [C18H21O6SN+H]+: 380.1168; 
found: 380.1152. 
 
 
Anti-4-(((benzyloxy)carbonyl)amino)-2,3-dihydroxybutyl butyrate (6k): 
Synthesized according to general procedure E for cross metathesis – 
dihydroxylation using allyl butyrate as the olefin in excess. The title compound 
was purified by column chromatography (50-70% ethyl acetate in hexanes) 
followed by preparatory thin layer chromatography (60% ethyl acetate in 
hexanes) to give a white solid (15.4 mg, 47%). 1H NMR (400 MHz, CDCl3-d6) δ 
7.39-7.29 (m, 5H), 5.37 (t, J = 7.2 Hz, 1H), 5.11 (s, 2H), 4.40 (dd, J = 12.0, 4.5 
Hz, 1H), 4.34-4.23 (m, 1H), 3.68-3.52 (m, 4H), 3.44-3.34 (m, 2H), 2.35 (dd, J = 
8.1, 6.8 Hz, 2H), 1.66 (hex, J = 7.4 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR 
(101 MHz, CDCl3) δ 175.2, 158.5, 136.2, 128.7, 128.5, 128.3, 71.2, 70.7, 67.5, 
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65.8, 43.5, 36.2, 18.5, 13.8. HRMS (FAB+): m/z calculated for [C16H23O6N+H]+: 
326.1604; found: 326.1613. 
 
 
Anti-4-(((benzyloxy)carbonyl)amino)-2,3-dihydroxybutyl benzoate (6l): 
Synthesized according to general procedure E for cross metathesis – 
dihydroxylation using allyl benzoate as the olefin in excess. The title compound 
was purified by column chromatography (50-70% ethyl acetate in hexanes) to 
give a clear oil (19.9 mg, 55%). 1H NMR (400 MHz, CDCl3-d6) δ 8.06 (d, J = 6.8 
Hz, 2H), 7.57 (ddt, J = 8.0, 7.0, 1.4 Hz, 1H), 7.43 (t, J = 7.8 Hz, 2H), 7.37-7.27 (m, 
5H), 5.46 (d, J = 6.7 Hz, 1H), 5.1 (s, 2H), 4.64 (dd, J = 12.0, 4.8 Hz, 1H), 4.52 (dd, 
J = 12.0, 2.5 Hz, 1H), 3.82-3.73 (m, 2H), 3.67-3.53 (m, 3H), 3.41 (ddd, J = 15.3, 
5.9, 2.6 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 167.9, 158.6, 136.2, 133.6, 130.0, 
129.6, 128.7, 128.6, 128.4, 128.3, 71.2, 70.9, 67.5, 66.5, 43.5. HRMS (FAB+): 
m/z calculated for [C19H21O6N+H]+: 360.1447; found: 360.1456. 
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Mechanistic experiments 
Dihydroxylation studies with (Z)-4-octene (8) and (Z)-but-2-ene-1,4-diyl diacetate 
(7): A solution of CeCl3 heptahydrate (3.7 mg, 0.01 mmol) in distilled H2O (170 
µL) was added to NaIO4 (42.8 mg, 0.2 mmol). MeCN (500 µL) was then added, 
and the mixture was cooled to 0 °C in an ice bath. A solution of Ru catalyst 4 
(0.001 mmol, 200 µL, 0.005 M in THF) was then added if required. Either (Z)-4-
octene 8 (11.2 mg, 0.1 mmol) and/or (Z)-but-2-ene-1,4-diyl diacetate 7 (17.2 mg, 
0.1 mmol) in ethyl acetate (0.5 ml) was then added. The mixture was vigorously 
stirred at 0 °C for 20 min and then quenched with 2 mL of a saturated Na2S2O3 
aqueous solution. The mixture was extracted with ethyl acetate (4 x 2.5 mL), and 
then concentrated under reduced pressure. Mesitylene was added as an internal 
standard (27.8 µL, 0.2 mmoL). The product distribution was analyzed by 1H NMR. 
 
Using (Z)-but-2-ene-1,4-diyl diacetate 7, without Ru: No dihydroxylation observed. 
Using (Z)-but-2-ene-1,4-diyl diacetate 7, with Ru: Anti-diol 6b was isolated in 
58% yield (11.9 mg), and no olefin starting material remains. 
Using (Z)-4-octene 8, with Ru: No dihydroxylation products observed  
Using (Z)-4-octene 8 and (Z)-but-2-ene-1,4-diyl diacetate 7, with Ru: No 
dihydroxylation products observed. 
 
Anti-2,3-dihydroxyhexyl benzoate (10): In a nitrogen filled glove box, 1-
pentene 9 (35.1 mg, 0.5 mmol, 5 eq) was added to allyl benzoate 5c (16.2 mg, 
 S18 
0.1 mmol, 1 eq) using Ad-DIPP-NO3 4 (0.003 mmol, 3 mol%, 150 µL, 0.02 M in 
THF) to quantitatively transfer to a Schlenk tube. The tube was capped, and then 
brought to a Schlenk line where it was evacuated using one freeze-pump-thaw 
cycle, capping the flask under static vacuum. The solution was then heated in an 
oil bath with stirring at 40 °C for 4 hr. Subsequently, the volatiles were removed 
with a high vacuum for 5 minutes. A solution of CeCl3 heptahydrate (3.7 mg, 0.01 
mmol, 10 mol%) in distilled H2O (170 µL) was added to NaIO4 (42.8 mg, 0.2 
mmol, 2 eq relative to the homodimerization metathesis product at full 
conversion). MeCN (500 µL) was then added, and the mixture was cooled to 0 °C 
in an ice bath. The crude metathesis mixture was then added, using ethyl acetate 
(3 x 167 µL) to rinse the flask and ensure complete transfer. The mixture was 
vigorously stirred at 0 °C for 20 min and then quenched with 2 mL of a saturated 
Na2S2O3 aqueous solution. The mixture was extracted with ethyl acetate (4 x 2.5 
mL), and then concentrated under reduced pressure. The anti-diol product was 
purified using preparatory thin layer chromatography (one purification at 50% 
ethyl acetate in hexanes, then a second purification at 30% ethyl acetate in 
hexanes) to yield a clear oil (7.9 mg, 33%). If this procedure is followed without 
removing volatiles after the metathesis step, no dihydroxylation is observed – 
only cross metathesis products. 1H NMR (500 MHz, CDCl3-d6) δ 8.05 (dd, J = 8.4, 
1.3 Hz, 1H), 7.59 (ddt, J = 7.7, 7.3, 1.4 Hz, 1H), 7.46 (tt, J = 8.0, 1.5 Hz, 1H), 
4.52 (s, 1H), 4.51 (d, J = 1.2 Hz, 1H), 3.91 (q, J = 4.9 Hz, 1H), 3.80-3.74 (m, 1H), 
2.64 (br s, 1H), 2.22 (br s, 1H), 1.65-1.50 (m, 3H), 1.45-1.37 (m, 1H), 0.97 (t, J = 
7.1 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 167.4, 133.5, 129.9, 129.8, 128.6, 
 S19 
73.3, 72.4, 66.3, 34.7, 19.2, 14.2; HRMS (FAB+): m/z calculated for 
[C13H18O4+H]+: 239.1283; found: 239.1285.  
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